Back
SPDR® S&P Pharmaceuticals ETF Vs. Invesco Biotechnology & Genome ETF Industry Stock Comparison
Buy
72
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
47.60
Seasonality Move:
5.14%
Buy
65
PBE
Invesco Biotechnology & Genome ETF
Last Price:
71.45
Seasonality Move:
5.51%
Buy
72
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $47.64. The Score for XPH is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- XPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Invesco Biotechnology & Genome ETF (PBE)
is a Buy
Is Invesco Biotechnology & Genome ETF a Buy, Sell or Hold?
- The current Invesco Biotechnology & Genome ETF [PBE] share price is $71.67. The Score for PBE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- PBE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $47.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing slight buying pressure.
PBE Stock Price Chart
What is Invesco Biotechnology & Genome ETF's stock price today?
-
The Invesco Biotechnology & Genome ETF share price today is $71.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBE is experiencing buying pressure, which is a positive indicator for future bullish movement.
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 66.68 | Buy |
| Chaikin Money Flow: | 8698 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.81 - 47.05) | Buy |
| Bollinger Bands (100): | (41.31 - 45.53) | Buy |
PBE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 63.27 | Buy |
| Chaikin Money Flow: | 3573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.89 - 69.97) | Buy |
| Bollinger Bands (100): | (66.8 - 70.84) | Buy |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.52 | Buy |
| 20-day SMA: | 46.41 | Buy |
| 50-day SMA: | 45.01 | Buy |
| 200-day SMA: | 42.65 | Buy |
| 8-day EMA: | 46.67 | Buy |
| 20-day EMA: | 46.17 | Buy |
| 50-day EMA: | 45.14 | Buy |
| 200-day EMA: | 42.92 | Buy |
PBE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.52 | Buy |
| 20-day SMA: | 69.04 | Buy |
| 50-day SMA: | 69.53 | Buy |
| 200-day SMA: | 66.37 | Buy |
| 8-day EMA: | 69.79 | Buy |
| 20-day EMA: | 69.26 | Buy |
| 50-day EMA: | 69.17 | Buy |
| 200-day EMA: | 66.76 | Buy |
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Invesco Biotechnology & Genome ETF Earnings Growth & PBE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Pharmaceuticals ETF Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Invesco Biotechnology & Genome ETF Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||